Lilly and Partners In Health, Brigham and Women's Hospital Team Up to Fight MDR-TB in Former Soviet Republics
Author: Eli Lilly, Partners in Health, Published on: 26 February 2008
Eli Lilly and Company and Partners In Health (PIH) today announced a series of multidrug-resistant tuberculosis (MDR-TB) trainings for health officials and physicians treating drug-resistant patients in 10 former Soviet Republics. The trainings will be conducted by experts from Brigham and Women's Hospital (BWH), a major Harvard University teaching hospital closely affiliated with PIH, and are funded as part of a $4 million grant made to PIH and BWH through The Lilly MDR-TB Partnership.
Related companies: Eli Lilly